A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy
Clinical trial NCT06467500 · RECRUITING
Trial details
- NCT number
- NCT06467500
- Sponsor
- Xin-Hua Xu
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2026-12-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.